if you start your day in work mode (4th & 5th gears), and you drive all day like that, you are going to burn out fast!
MAPS speaks with Annemarie Clegg, CMO, OPEN Health, about the evolving role of Medical Affairs in providing context for payers, regulators and policy makers whose decisions can dramatically affect which patients can access industry innovations.
This podcast discusses the how and why this group of MI professionals, who are part of phactMI, a nonprofit collaboration of Medical Information leaders, came together and the lessons learned from their collaboration. Â
In this podcast, MAPS speaks with Renu Juneja, who started a medical writing fellowship program at Janssen, and with two of her former fellowship participants, Jennifer Lee and Lauren Brown.
This webinar will be covering:
1.   Looking into the future of MA in Japan
a.   How to engage more with Patients/Patient Advocacy groups
b.   How to bring more value to customers, scientific leaders and health systems
c.    How to better engage academia and health authority group through scientific exchange
2.   Opportunities for improving effectiveness
a.   Differentiation of MSL and Medical Rep roles- how are companies differentiating despite the regulations?
During this webinar, experts will:
This podcast details how Renu Juneja went from earning a PhD in the pharmaceutical industry to becoming a medical writer at Novo Nordisk.
Standards and Guidance powerpoint and templates for Medical Affairs strategic planning
This white paper by the MAPS Executive Consortium synthesizes the views of senior global Medical Affairs leaders to provide a unified vision for the future of Medical Affairs in society, industry, teams and as individuals.
This webinar will provide an overview of the evolution of the Medical Affairs role and contributions to scientific congresses. We will revisit the good old days of in person congress engagement pivoting to highlight the innovations scientific exchange today. We will also discuss the elements of transitioning to a completely virtual platform due to the COVID-19 pandemic which provided an opportunity to re-evaluate the medical affairs approach. Which activities and educational resources were of high-value and could be improved upon further? Lastly, we will touch upon future congresses experiences. What will HCP engagement consist of– live, virtual, hybrid, etc. Based upon these new opportunities are our metrics and KPIs effective?
1. Identify opportunities to leverage the congress experience to enhance scientific exchange
2. Explore strategies to harmonize in-person and digital medical affairs engagement